Research initiative focused on valorising pectin extraction by-products, beginning with polyphenol recovery from apple pomace. Apples are a rich source of powerful antioxidants, and the global polyphenol market is expanding 5-15% annually. The program aims to develop economically viable extraction technologies for applications in medical and bulk chemical sectors, progressing from feasibility studies through scale-up, patent protection, and commercial production.
This research program, led by a professor of Industrial Biotechnology at a leading European chemical engineering school, focuses on valorising by-products from the pectin extraction industry. The initial technical target is the extraction of polyphenols from apple pomace — the solid residue generated during apple processing. Apple pomace is a rich source of powerful antioxidants with significant commercial potential across multiple sectors.
The global polyphenol market is expanding at 5–15% per year, driven by demand in medical, nutraceutical, and bulk chemical applications. This initiative aims to identify not one but several technical solutions for converting pectin extraction by-products into valuable products, beginning with polyphenol recovery.
Research approach:
Key focus areas:
The research lead brings prior industrial experience in by-product valorisation from the brewing industry, with a notable record of industrial success, as well as an established network for this project.
This technology is at an early concept stage (TRL 1–2). The proposed roadmap includes: